Pharmacological Protection From Radiation ± Cisplatin-Induced Oral Mucositis
Authors:
- 23 December 2011
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 83 (4) , 1284-1290
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Pharmacokinetic Analysis and Phase 1 Study of MRX-1024 in Patients Treated with Radiation Therapy with or without Cisplatinum for Head and Neck CancerClinical Cancer Research, 2010
- Radioprotectors and Mitigators of Radiation-Induced Normal Tissue InjuryThe Oncologist, 2010
- Prevention of Radiation-Induced Oral Mucositis after Adenoviral Vector–Mediated Transfer of the Keratinocyte Growth Factor cDNA to Mouse Submandibular GlandsClinical Cancer Research, 2009
- Evaluation of d-Methionine as a Novel Oral Radiation Protector for Prevention of MucositisClinical Cancer Research, 2008
- Differential Radiation Protection of Salivary Glands versus Tumor by Tempol with Accompanying Tissue Assessment of Tempol by Magnetic Resonance ImagingClinical Cancer Research, 2007
- Kinetics of Tempol for Prevention of Xerostomia Following Head and Neck Irradiation in a Mouse ModelClinical Cancer Research, 2005
- Palifermin for Oral Mucositis after Intensive Therapy for Hematologic CancersNew England Journal of Medicine, 2004
- A Phase I Study of Topical Tempol for the Prevention of Alopecia Induced by Whole Brain RadiotherapyClinical Cancer Research, 2004
- Evaluation of Tempol Radioprotection in a Murine Tumor ModelFree Radical Biology and Medicine, 1997
- Treatment of acetaminophen poisoning. The use of oral methionineArchives of internal medicine (1960), 1981